Printer Friendly 14,734,713 articles and books

Periodicals Literature Keyword Title Author Topic

Member login User name    Password    Remember me Join us Forgot password?

Submit articles free

Browse Antibiotics topic

Product development subtopic

Articles 1-30 out of 30 article(s) Title Author Type Date Words PolyMedix Successfully Completes Main Portions of Phase 1B Clinical Study with PMX-30063 Novel Antibiotic Drug Candidate. Dec 18, 2009 2064 Anacor Initiates Phase I Clinical Development for AN3365 - A Novel Antibiotic for the Treatment of Gram-Negative Infections. Nov 17, 2009 588 Achaogen Announces ACHN-490 Clinical Data at the 49th Annual ICAAC Meeting. Conference news Sep 14, 2009 803 FAB Pharma, a Biopharma Company Developing Drugs to Treat Severe Bacterial Infections, Raises [euro]2.3 Million in Series A Funding and Begins Recruitment for a Phase I Trial of Its Lead Compound. Sep 12, 2009 431 Cempra Pharmaceuticals Initiates Phase 2/3 Clinical Study for an Oral Antibiotic to Treat Acute Bacterial Skin Structure Infections. Clinical report Sep 9, 2009 506 InSite Vision Announces Clinical Development Plan for ISV-502. Jun 8, 2009 1318 PolyMedix Initiates Dosing in Second Phase I Clinical Study of Novel Systemic Antibiotic Compound. Jun 5, 2009 1295 PolyMedix Receives Regulatory Clearance to Initiate Second Phase I Clinical Study of Novel Systemic Antibiotic Compound. May 21, 2009 1178 PolyMedix Announces Positive Phase I Clinical Data with PMX-30063 Novel Antibiotic Drug Candidate. Dec 10, 2008 2177 InSite Vision Announces Preliminary Results From Phase 3 Clinical Trial of ISV-502 for the Treatment of Eyelid Inflammation and Infection. Dec 8, 2008 1451 Targanta Therapeutics Announces Positive Top-Line Results from Oritavancin Phase 2 SIMPLIFI Trial. Financial report Sep 2, 2008 924 PolyMedix Initiates Dosing in Phase I Clinical Study of Novel Systemic Antibiotic Compound. Aug 21, 2008 1186 Post-Patent pendency inclemency: Trailblazing with blindfolds: Examining strategies your company can employ when your patents are pending. Almada, Anthony Jul 1, 2008 834 Targanta's Oritavancin MAA Accepted for Review by EMEA. Jun 25, 2008 877 Targanta Completes Enrollment in Phase 2 Oritavancin Infrequent Dosing Study. May 20, 2008 930 Salix Presents New Rifaximin Phase IIb Data Demonstrating Significant and Sustained Improvement in Diarrhea-Associated Irritable Bowel Syndrome (D-IBS). May 20, 2008 1488 Protez Initiates Phase II Study for Its Lead Product PZ-601 in Infectious Diseases. May 2, 2008 464 FDA cites Sanofi for shoddy study oversight. Nov 5, 2007 252 Oculus Initiates Patient Enrollment in Phase II Study of Microcyn(R) Technology for Treatment of Mild Diabetic Foot Infections. Clinical report May 21, 2007 837 Oculus Announces Initial Sites for Phase II Clinical Trial of Microcyn(R) Technology in Treatment of Mild Diabetic Foot Infections. Mar 29, 2007 715 REPEAT/FDA Approves New Indication for INVANZ(R) (ertapenem) for the Prevention of Surgical Site Infections (SSI) following Elective Colorectal Surgery in Adults. Dec 21, 2006 12745 FDA Approves New Indication for INVANZ(R) (ertapenem) for the Prevention of Surgical Site Infections (SSI) following Elective Colorectal Surgery in Adults. Dec 20, 2006 12745 Germ zapper. Sohn, Emily Brief article May 24, 2006 318 The FDA:s antibiotic resistance: if bacteria are becoming increasingly resistant to current antibiotics, why is the FDA discouraging the development of new antibiotics? Rubin, Paul H. Dec 22, 2004 2878 Advancis continues to expand patent estate covering antibiotic dosing. Feb 1, 2004 521 Salix Pharmaceuticals. (Regional Report: Triangle). Brief Article Jan 1, 2003 41 Studies of the antibiotic Cytosporone E. (South Carolina Academy of Sciences Abstracts). Hall, Jeffrey D. Brief Article Jan 1, 2003 77 GlaxoSmithKline. (Regional Report: Triangle). Brief Article Dec 1, 2002 44 Dade MicroScan Inc. Receives FDA Approval for New Strep Testing Procedure. Dec 26, 1996 247 GALAGEN ANNOUNCES PROMISING PHASE I/II CLINICAL RESULTS FOR SPORIDIN-G IN THE JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROME AND HUMAN RETROVIROLOGY. Dec 2, 1996 883

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles